Definitely looking forward to the January 21 Shareholder meeting. Since the company is coming back online it appears that it has some serious potential in the graphene market and with COVID mitigation and prevention. Vaccines are very helpful but not instantaneous as manufacturing and distribution constraints will force the rollouts deep into 2021 and into 2022 to inoculate a majority of the world population (not to mention mutations issues). Therefore, the VSS product might have some decent staying power, especially in lower level global economies. Pretty interesting stuff and only 4 weeks or so away from learning more about their new business plan.
News 
Market Data 
Discover 
AI
